China Pharma Holdings reported that its second-quarter net income was $5.1 million, or $0.12 per share, down from $6.1 million, or $0.14 per share, in the second quarter of 2010. Excluding the effect of change in fair value of derivative warrant liability, adjusted non-GAAP net income in the second quarter of 2011 was $4.8 million, or $0.11 per share, compared to $5.3 million, or $0.12 per share, in the second quarter of 2010.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
